Table 4.
Prediction of Post-acute Relapse or Recurrence from Stressful Life Events and CT Skills
| Predictors | B | SE | p |
|---|---|---|---|
| Post-acute HRSD | −0.01 | 0.17 | .95 |
| Continuation arm | X2(3) = 3.59, p = .31 | ||
| Higher risk: C-CT | −0.20 | 0.28 | .47 |
| Higher risk: FLX | 0.18 | 0.24 | .46 |
| Higher risk: PBO | 0.17 | 0.24 | .49 |
| Lower risk: Assessment only | --- | --- | --- |
| Stressful life events (SLE) | 0.11 | 0.18 | .53 |
| Cognitive therapy (CT) skills | −0.17 | 0.18 | .34 |
| Continuation arm * SLE | X2(3) = 9.77, p = .02 | ||
| C-CT * SLE | 0.53 | 0.26 | .04 |
| FLX * SLE | −0.04 | 0.23 | .87 |
| PBO * SLE | −0.15 | 0.25 | .54 |
| Assessment only * SLE | --- | --- | --- |
| Continuation arm * CT skills | X2 (3) = 4.90, p = .18 | ||
| C-CT * skills | −0.12 | 0.29 | .68 |
| FLX * skills | 0.02 | 0.26 | .94 |
| PBO * skills | −0.37 | 0.27 | .17 |
| Assessment only * CT skills | --- | --- | --- |
| SLE * CT skills | −0.58 | 0.21 | .006 |
Note. N = 152. The Cox regression model predicted time to relapse/recurrence (over 32 months) after response to acute-phase cognitive therapy. Predictors were standardized. HRSD = Hamilton Rating Scale for Depression. C-CT = continuation cognitive therapy. FLX = continuation fluoxetine plus clinical management. PBO = continuation pill placebo plus clinical management.